BioLife Solutions, Inc., a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, has announced the acquisition of privately-held PanTHERA CryoSolutions, Inc., a developer of novel cryopreservation solutions based on proprietary Ice Recrystallization Inhibitor technology. The acquisition further strengthens BioLife's position as the market leader in biopreservation, enhancing its product portfolio of consumable solutions and adds scientific capabilities to the management team.
Bennett Jones acted as Canadian counsel to BioLife.
The Bennett Jones team was led by James Beeby and Jeff Taylor (M&A) and included Talia Bregman, Katelyn Weller (Employment), Marshall Haughey (Tax), Sebastien Gittens (Intellectual Property), Allyson Marta (Pensions and Benefits), Jennifer Huang and Amelia Neo (Corporate).
Read the transaction< a href="https://investors.biolifesolutions.com/2025-04-07-BioLife-Solutions-Acquires-PanTHERA-CryoSolutions-to-Advance-Leadership-as-a-Pure-Play-Bioproduction-Consumables-Company" target="_blank" rel="noopener noreferrer">press release.